Objective To compared the prognosis between infants with biliary atresia ( BA) who underwent living donor liver transplantation ( LDLT) during 2006- 2009 and 2010- 2012 in the Department of Liver Surgery, Renji Hospital, Shanghai Jiaotong University School of Medicine and to evaluate the prognos is of LDLT performed during different periods. Methods A retrospective analysis was performed on the clinical data of 101 infants with BA who underwent LDLT from October 2006 to December 2012. These patients were divided into 2006- 2009 group and 2010- 2012 group according to the year the procedure was performed. The two groups were compared in terms of preoperative general data, intraoperative status, and treatment outcome. The Kaplan- Meier method was used for survival analysis; measurement data were analyzed by t test, and enumeration data were analyzed by Fisher exact probability test and chi- square test. Results The preoperative general data showed no significant difference between the two groups. Compared with the 2006- 2009 group, the 2010- 2012 group had significantly less intraoperative blood loss ( t = 2. 05, P = 0. 04) , a significantly shorter cold ischemia time of donor liver ( t = 3. 25, P < 0. 01) , and significantly lower incidence of postoperative biliary complications ( χ2= 4. 27, P = 0. 04) , pulmonary infection ( χ2= 4. 47, P = 0. 03) , and acute rejection ( P = 0. 03) . The 2010- 2012 group had significantly improved survival compared with the 2006- 2009 group; the 1 and 2 year cumulative survival rates for the 2010- 2012 group were 88. 4% and 88. 4%, respectively, versus 84. 4% and 75% for the 2006- 2009 group. Conclusion The development of surgical techniques, improvement in perioperative management, and standardized follow- up can significantly increase the success rate of surgery and survival rate and reduce postoperative complications in BA patients.
[1]BRINDLEY SM, LANHAM AM, KARRER FM, et al.Cytomegalovirus-specific T-cell reactivity in biliary atresia at the time of diagnosis is associated with deficits in regulatory T cells[J].Hepatology, 2012, 55 (4) :1130-1138.
|
[2]CUI S, LEYVA-VEGA M, TSAI EA, et al.Evidence from human and zebrafish that GPC1 is a biliary atresia susceptibility gene[J].Gastroenterology, 2013, 144 (5) :1107-1115, e1103.
|
[3]CHEN CL, CONCEJERO A, WANG CC, et al.Living donor liver transplantation for biliary atresia:a single-center experience with first 100 cases[J].Am J Transplant, 2006, 6 (11) :2672-2679.
|
[4]XIA Q, LI QG.Surgical treatment of congenital atresia of biliary duct[J].J Clin Surg, 2007, 15 (4) :222-223. (in Chinese) 夏强, 李齐根.先天性胆道闭锁的外科治疗[J].临床外科杂志, 2007, 15 (4) :222-223.
|
[5]GOSS JA, SHACKLETON CR, MCDIARMID SV, et al.Longterm results of pediatric liver transplantation:an analysis of 569transplants[J].Ann Surg, 1998, 228 (3) :411-420.
|
[6]FARMER DG, VENICK RS, MCDIARMID SV, et al.Predictors of outcomes after pediatric liver transplantation:an analysis of more than 800 cases performed at a single institution[J].J Am Coll Surg, 2007, 204 (5) :904-916.
|
[7]ZHU JJ, XIA Q, ZHANG JJ, et al.Forty-four living donor liver transplantations for children with biliary atresia[J].Chin J Organ Transplant, 2011, 32 (7) :415-418. (in Chinese) 朱建军, 夏强, 张建军, 等.活体肝移植治疗儿童胆道闭锁44例[J].中华器官移植杂志, 2011, 32 (7) :415-418.
|
[8]TANG XY, XIA Q, ZHANG JJ, et al.Application of immunosuppressive agents in children with pediatric living-donor liver transplantation[J].Chin J Organ Transplant, 2012, 33 (5) :283-286. (in Chinese) 汤晓寅, 夏强, 张建军, 等.小儿活体肝移植后免疫抑制剂的应用体会[J].中华器官移植杂志, 2012, 33 (5) :283-286.
|
[9]RAIA S, NERY JR, MILES S.Liver transplantation from live donors[J].Lancet, 1989, 2 (8661) :497.
|
[10]MCDIARMID SV, ANAND R, LINDBLAD AS.Studies of Pediatric Liver Transplantation:2002 update.An overview of demographics, indications, timing, and immunosuppressive practices in pediatric liver transplantation in the United States and Canada[J].Pediatr Transplant, 2004, 8 (3) :284-294.
|
[11]OHI R, MOCHIZUKI I, KOMATSU K, et al.Portal hypertension after successful hepatic portoenterostomy in biliary atresia[J].J Pediatr Surg, 1986, 21 (3) :271-274.
|
[12]OTTE JB, de VILLE de GOYET J, REDING R, et al.Sequential treatment of biliary atresia with Kasai portoenterostomy and liver transplantation:a review[J].Hepatology, 1994, 20 (1 Pt 2) :s41-s48.
|
[13]MAHADEB P, GRAS J, SOKAL E, et al.Liver transplantation in children with fulminant hepatic failure:The UCL experience[J].Pediatr Transplant, 2009, 13 (4) :414-420.
|
[14]LEE KW, CAMERON AM, MALEY WR, et al.Factors affecting graft survival after adult/child split-liver transplantation:analysis of the UNOS/OPTN data base[J].Am J Transplant, 2008, 8 (6) :1186-1196.
|
[15]BOURDEAUX C, TRI TT, GRAS J, et al.PELD score and posttransplant outcome in pediatric liver transplantation:a retrospective study of 100 recipients[J].Transplantation, 2005, 79 (9) :1273-1276.
|
[16]MCDIARMID SV, ANAND R, MARTZ K, et al.A multivariate analysis of pre-, peri-, and post-transplant factors affecting outcome after pediatric liver transplantation[J].Ann Surg, 2011, 254 (1) :145-154.
|
[17]EVRARD V, OTTE JB, SOKAL E, et al.Impact of surgical and immunological parameters in pediatric liver transplantation:a multivariate analysis in 500 consecutive recipients of primary grafts[J].Ann Surg, 2004, 239 (2) :272-280.
|
[18]XIA Q, ZHANG JJ, LI QG, et al.Pediatric living donor liver transplantation:a report of 33 cases[J].Chin J Dig Surg, 2011, 10 (1) :40-43. (in Chinese) 夏强, 张建军, 李齐根, 等.婴幼儿活体肝移植33例[J].中华消化外科杂志, 2011, 10 (1) :40-43.
|
[19]TAKAHASHI Y, NISHIMOTO Y, MATSUURA T, et al.Surgical complications after living donor liver transplantation in patients with biliary atresia:a relatively high incidence of portal vein complications[J].Pediatr Surg Int, 2009, 25 (9) :745-751.
|
[20]MIZUTA K, SANADA Y, WAKIYA T, et al.Living-donor liver transplantation in 126 patients with biliary atresia:single-center experience[J].Transplant Proc, 2010, 42 (10) :4127-4131.
|
[21]WOJCICKI M, MILKIEWICZ P, SILVA M.Biliary tract complications after liver transplantation:a review[J].Dig Surg, 2008, 25 (4) :245-257.
|
[22]OH SH, KIM KM, KIM DY, et al.Long-term outcomes of pediatric living donor liver transplantation at a single institution[J].Pediatr Transplant, 2010, 14 (7) :870-878.
|
[23]AALAMI OO, ALLEN DB, ORGAN CH JR.Chylous ascites:a collective review[J].Surgery, 2000, 128 (5) :761-778.
|
[24]MARTIN SR, ATKISON P, ANAND R, et al.Studies of Pediatric Liver Transplantation 2002:patient and graft survival and rejection in pediatric recipients of a first liver transplant in the United States and Canada[J].Pediatr Transplant, 2004, 8 (3) :273-283.
|
[1] | Decai KONG, Xiaojing ZHANG, Yangguang YUN, Haoyu DUAN, Junfeng YE. Risk factors for biliary stricture and prognosis after orthotopic liver transplantation[J]. Journal of Clinical Hepatology, 2024, 40(11): 2253-2259. doi: 10.12449/JCH241119 |
[2] | Rongjuan SUN, Jianghua ZHAN. Research advances in the diagnostic methods for biliary atresia[J]. Journal of Clinical Hepatology, 2022, 38(7): 1681-1685. doi: 10.3969/j.issn.1001-5256.2022.07.043 |
[3] | Lin CHEN, Ning LIU, Jinglan JIN, Yanjun CAI, Fang XU, Junqi NIU, Wanyu LI. Research status and challenges in the prognosis of primary biliary cholangitis after liver transplantation[J]. Journal of Clinical Hepatology, 2021, 37(4): 955-958. doi: 10.3969/j.issn.1001-5256.2021.04.050 |
[4] | Xing DAI, Ben GAO, Jiang LI. Research advances in improving the prognosis of recipients of fatty liver transplantation[J]. Journal of Clinical Hepatology, 2021, 37(12): 2967-2971. doi: 10.3969/j.issn.1001-5256.2021.12.049 |
[5] | Yuxuan LI, Wenya LIU. Research advances in the value of sarcopenia in the prognosis of patients after liver transplantation[J]. Journal of Clinical Hepatology, 2021, 37(6): 1469-1472. doi: 10.3969/j.issn.1001-5256.2021.06.052 |
[6] | Zhang DaLi, Feng DanNi, Zhang LiJuan, Tang RuJia, He Xi, Zhou Xia, Gao YinJie, Liu ZhenWen, Liu HongLing. Risk factors for recurrence after liver transplantation in patients with hepatocellular carcinoma and their prognosis[J]. Journal of Clinical Hepatology, 2020, 36(9): 1985-1989. doi: 10.3969/j.issn.1001-5256.2020.09.015 |
[7] | Chen WeiTing, Li ShuangJie. Clinical value of transient elastography,aspartate aminotransferase-to-platelet ratio index,and fibrosis-4 in the diagnosis of liver fibrosis in children with biliary atresia[J]. Journal of Clinical Hepatology, 2020, 36(3): 546-550. doi: 10.3969/j.issn.1001-5256.2020.03.015 |
[8] | Lu YeFeng, Xia Qiang, Qiu BiJun, Feng MingXuan, Wan Ping. An analysis of related issues in long-term survival in children after liver transplantation[J]. Journal of Clinical Hepatology, 2019, 35(11): 2396-2401. doi: 10.3969/j.issn.1001-5256.2019.11.004 |
[9] | Section of Hepatobiliary Surgery, Branch of Pediatric Surgery, Chinese Medical Association, Section of Pediatric Hepatic Transplantation, Branch of Organ Transplantation, Chinese Medical Doctor Association. Guidelines for diagnosing & treating biliary atresia (2018 Edition)[J]. Journal of Clinical Hepatology, 2019, 35(11): 2435-2440. doi: 10.3969/j.issn.1001-5256.2019.11.009 |
[10] | Huang CaiZhi, Nie BoLi, Tang Lian, Mo LiYa. Correlation of severity of infantile cholestatic liver disease with serum vitamin D level[J]. Journal of Clinical Hepatology, 2019, 35(8): 1782-1785. doi: 10.3969/j.issn.1001-5256.2019.08.026 |
[11] | Jiang Chao, Huang HeYu, Lu: GuoYue. Perspectives of liver transplantation for infantile cholestatic liver disease[J]. Journal of Clinical Hepatology, 2017, 33(10): 1928-1930. doi: 10.3969/j.issn.1001-5256.2017.10.015 |
[12] | Han HuanLi, Zhang MingMan, Guo ChunBao, Kang Quan, Li YingCun, Pu CongLun. An analysis of postoperative complications in children with biliary atresia after liver transplantation[J]. Journal of Clinical Hepatology, 2017, 33(2): 316-319. doi: 10.3969/j.issn.1001-5256.2017.02.024 |
[13] | Zhang Jing, Zhou XinMin. Disease assessment and prognosis of liver failure[J]. Journal of Clinical Hepatology, 2016, 32(9): 1673-1677. doi: 10.3969/j.issn.1001-5256.2016.09.008 |
[14] | Chen Gong, Zheng Shan. Common clinical problems during treatment of neonatal biliary atresia[J]. Journal of Clinical Hepatology, 2015, 31(8): 1226-1229. doi: 10.3969/j.issn.1001-5256.2015.08.011 |
[15] | Guo ZhenYa, Zhang RuoYan, Liu MingJiang, Du XiaoHong, Zhang Ping, Wang GuangYi, Ye JunFeng. Research progress in causes of congenital biliary atresia[J]. Journal of Clinical Hepatology, 2015, 31(8): 1343-1346. doi: 10.3969/j.issn.1001-5256.2015.08.043 |
[16] | Pang XiaoLi, Wang ChaoXia. Relationship of intestinal microecology with infantile cholestatic liver disease[J]. Journal of Clinical Hepatology, 2015, 31(8): 1221-1225. doi: 10.3969/j.issn.1001-5256.2015.08.010 |
[17] | Liu Yan, Huang ZhiHua. Clinical diagnosis and treatment of cholestatic hepatopathy in infants[J]. Journal of Clinical Hepatology, 2015, 31(8): 1218-1220. doi: 10.3969/j.issn.1001-5256.2015.08.009 |
[18] | Guo Jing, Xu LingFen, Sun Mei. Differential diagnosis of biliary atresia and intrahepatic cholestasis in children[J]. Journal of Clinical Hepatology, 2015, 31(8): 1252-1256. doi: 10.3969/j.issn.1001-5256.2015.08.017 |
[19] | Jiang Tao, Yao Yu, Ou YangWenXian, Tan YanFang, Li ShuangJie. Intrahepatic cholestasis caused by citrin deficiency: a clinical analysis of 43 infants[J]. Journal of Clinical Hepatology, 2014, 30(11): 1123-1126. doi: 10.3969/j.issn.1001-5256.2014.11.007 |
[20] | Zhu Peng, Wang YuMing. NASPGHAN practice guidelines: diagnosis and management of hepatitis C infection in infants, children, and adolescents[J]. Journal of Clinical Hepatology, 2013, 29(10): 726-731. doi: 10.3969/j.issn.1001-5256.2013.10.002 |